Antimicrobial susceptibility of Salmonella typhi to quinolones & cephalosporins. 1998

K G Bhat, and A T Andrade, and S G Karadesai, and B M Hemashettar, and C S Patil
Department of Microbiology, J.N. Medical College, Belgaum.

Antimicrobial sensitivity testing was carried out for 85 isolates of S. typhi by disc diffusion and microbroth dilution for estimation of minimum inhibitory concentration (MIC). The drugs used included amoxycillin, chloramphenicol, ciprofloxacin, ofloxacin, gentamicin, netilmicin, cefuroxime, ceftizoxime, cefoperazone and ceftazidime. Ninety three per cent of our isolates were resistant to amoxycillin and chloramphenicol but total susceptibility was seen to quinolones and aminoglycosides. We also found that 3 per cent of our isolates were resistant to cephalosporins and 23 per cent were in the intermediate range with an MIC of 12.5 or 25 micrograms/ml to these drugs. In spite of decreased efficacy, the strains continued to be fully susceptible to ciprofloxacin as could be seen from the extended dilutions in microbroth dilution tests. The study also revealed that there was lack of correlation between the two methods of sensitivity testing for cephalosporins. We feel that the development of resistance of S. typhi to third generation cephalosporins is a finding worth consideration for further studies.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D012485 Salmonella typhi A serotype of SALMONELLA ENTERICA which is the etiologic agent of TYPHOID FEVER. Salmonella enterica serovar Typhi,Salmonella typhosa
D042462 4-Quinolones QUINOLONES containing a 4-oxo (a carbonyl in the para position to the nitrogen). They inhibit the A subunit of DNA GYRASE and are used as antimicrobials. Second generation 4-quinolones are also substituted with a 1-piperazinyl group at the 7-position and a fluorine at the 6-position. 4-Oxoquinoline,4-Quinolinone,4-Quinolone,4-Oxoquinolines,4-Quinolinones,4 Oxoquinoline,4 Oxoquinolines,4 Quinolinone,4 Quinolinones,4 Quinolone,4 Quinolones

Related Publications

K G Bhat, and A T Andrade, and S G Karadesai, and B M Hemashettar, and C S Patil
January 2002, Indian journal of medical sciences,
K G Bhat, and A T Andrade, and S G Karadesai, and B M Hemashettar, and C S Patil
March 2010, Journal of infection in developing countries,
K G Bhat, and A T Andrade, and S G Karadesai, and B M Hemashettar, and C S Patil
November 2007, Emerging infectious diseases,
K G Bhat, and A T Andrade, and S G Karadesai, and B M Hemashettar, and C S Patil
January 1993, Drugs,
K G Bhat, and A T Andrade, and S G Karadesai, and B M Hemashettar, and C S Patil
May 2001, The Central African journal of medicine,
K G Bhat, and A T Andrade, and S G Karadesai, and B M Hemashettar, and C S Patil
January 1997, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
K G Bhat, and A T Andrade, and S G Karadesai, and B M Hemashettar, and C S Patil
August 2004, The Indian journal of medical research,
K G Bhat, and A T Andrade, and S G Karadesai, and B M Hemashettar, and C S Patil
May 2007, The Southeast Asian journal of tropical medicine and public health,
K G Bhat, and A T Andrade, and S G Karadesai, and B M Hemashettar, and C S Patil
March 2007, Journal of health, population, and nutrition,
K G Bhat, and A T Andrade, and S G Karadesai, and B M Hemashettar, and C S Patil
February 2007, Journal of chemotherapy (Florence, Italy),
Copied contents to your clipboard!